Close

Form SC 13G/A Sucampo Pharmaceuticals, Filed by: S&R Technology Holdings, LLC

February 13, 2015 5:13 PM EST

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934

Amendment No. 6

 

 

SUCAMPO PHARMACEUTICALS, INC.

(Name of Issuer)

CLASS A COMMON STOCK

(Title of Class of Securities)

864909106

(CUSIP Number)

DECEMBER 31, 2014

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

Check the following box if a fee is being paid with this statement.  ¨

 

 

 


CUSIP No.: 864909106  

 

  (1)   

Name of reporting person

I.R.S. Identification No. of Above Person

 

S&R TECHNOLOGY HOLDINGS, LLC

52-2242847

  (2)  

Check the appropriate box if a member of a group

(a)  ¨        (b)  ¨

 

  (3)  

SEC use only

 

  (4)  

Citizenship

 

    DELAWARE

Number of

shares

beneficially

owned by

each

reporting

person

with

   (5)    

Sole voting power

 

    21,460,802

   (6)   

Shared voting power

 

    0

   (7)   

Sole dispositive power

 

    21,460,802

   (8)   

Shared dispositive power

 

    0

  (9)  

Aggregate amount beneficially owned by each reporting person

 

    21,460,802

(10)  

Check box if the aggregate amount in Row (9) excludes certain shares     ¨

 

(11)  

Percent of class represented by amount in Row (9)

 

    48.4%

(12)  

Type of reporting person

 

    OO

 


Item 1(a). Name of Issuer

SUCAMPO PHARMACEUTICALS, INC.

 

Item 1(b). Address of Issuer’s Principal Executive Offices

4520 EAST-WEST HIGHWAY

SUITE 300

BETHESDA, MD 20814

 

Item 2(a). Name of Person Filing

S&R TECHNOLOGY HOLDINGS, LLC

 

Item 2(b). Address of Principal Business Office or, if none, Residence

7501 WISCONSIN AVENUE

SUITE 600E

BETHESDA, MD 20814-6519

 

Item 2(c). Citizenship

DELAWARE

 

Item 2(d). Title of Class of Securities

CLASS A COMMON STOCK

 

Item 2(e). CUSIP No.

864909106

 

Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c):

NOT APPLICABLE

 

Item 4. Ownership

 

  (a) Amount beneficially owned:

21,460,802

 

  (b) Percent of class:

48.4%

 

3


  (c) Number of shares as to which the person has:

 

  (i) Sole power to vote or to direct the vote:

21,460,802

 

  (ii) Shared power to vote or to direct the vote:

0

 

  (iii) Sole power to dispose or to direct the disposition of:

21,460,802

 

  (iv) Shared power to dispose or to direct the disposition of:

0

 

Item 5. Ownership of Five Percent or Less of a Class

NOT APPLICABLE

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

NOT APPLICABLE

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

NOT APPLICABLE

 

Item 8. Identification and Classification of Members of the Group

NOT APPLICABLE

 

Item 9. Notice of Dissolution of Group

NOT APPLICABLE

 

Item 10. Certifications

NOT APPLICABLE

 

4


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 13, 2015 S&R TECHNOLOGY HOLDINGS, LLC
By:

/s/ Kei Tolliver

Name: Kei Tolliver
Executive Vice President

 

5



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G